Locations

Victoria, Australia · Brisbane, QLD, Australia · Sydney, NSW, Australia · Cambridge, MA, USA · Sydney NSW, Australia

industry

Biotechnology

Size

51 - 200 employees

Stage

Other

founded in

2011

Vaxxas is a clinical-stage biotechnology company commercializing HD-MAP, a needle-free vaccine delivery system. Instead of conventional needles, HD-MAP uses tiny projections coated with dried vaccine, applied to the skin via a small patch and applicator. This innovation delivers the vaccine directly to immune cells just beneath the skin, triggering strong immune responses with potentially lower doses.

Something looks off?
Open jobs at Vaxxas
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.